HOME >> BIOLOGY >> NEWS
ECCO 12 - the European Cancer Conference

ECCO 12 the European Cancer Conference
Sunday 21 September Thursday 25 September 2003
Bella Center A/S, Center Boulevard, Copenhagen, Denmark

Join 10,000 international cancer experts at ECCO 12 Europe's premier cancer conference: the only forum in Europe covering the entire spectrum of research, treatment and care for all types of tumours. An opportunity to hear the latest research findings and sit in on debates and discussions on controversies in cancer.

  • Registration free for all media providing bona fide press credentials
  • All sessions open to journalists
  • A fully equipped media centre with computers and free phone and internet facilities
  • Daily news briefings

    News briefing programme (subject to confirmation):

    Sunday 21 September 17.00hrs:

    • Join EU and FECS' representatives for a Round Table discussion on R and D challenges in cancer and the growing problem of unequal access to cancer care in Europe. Your chance to quiz the experts.

    Monday 22 September 13.00hrs:

    • Dr Michael Stratton: Cancer genes - a realistic target for drug development?
    • Dr Nicolaj Andreassen: Tailoring radiotherapy - new findings predict sensitivity to radiation damage
    • Prof. Richard Peto: Hormonal treatment in prostate & breast cancer latest findings on increasing 10-year survival

    Tuesday 23 September 13.00hrs

    • Prof Anthony Howell: Update on ATAC [Arimidex, Tamoxifen Alone or in Combination] trial
    • Prof Peter Ravdin: First head-to-head paclixtaxel v docetaxel trial in breast cancer world-first presentation of findings
    • Lynn Faulds-Wood & Kathy Redmond launch of the European Cancer Patient Coalition (ECPC) Europe's first patient advocacy group for all types of cancer

    Wednesday 24 September 13.00hrs

    • Prof Jens Overgaard: Shorter radiotherapy helps head and neck can
      '"/>


    Contact: Margaret Willson
    m.willson@mwcommunications.org.uk
    44-015-367-72181
    Federation of European Cancer Societies
    20-Aug-2003


    Page: 1 2

    Related biology news :

    1. European common frog found to use novel mating strategy
    2. Zoonotic diseases - European scientists unite to fight diseases
    3. Second call for proposals for the European Young Investigator Award
    4. Common call for action on European Research Council (ERC)
    5. EURYI Award given for the first time to 25 young European researchers
    6. European researchers tackle mitosis
    7. Key principles for the foundation of a European Research Council (ERC)
    8. EC boosts European electron microscopy research
    9. Plants for the future: A European vision for plant biotechnology towards 2025
    10. European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer
    11. Limited climate tracking in European trees despite 10,000 years of postglacial warmth

  • Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:4/12/2019)... ... April 11, 2019 , ... Neal O’Farrell is one of the first ... He is executive director of the consumer advocacy non-profit the Identity Theft Council as ... member of the Federal Communications Commission’s Cybersecurity Roundtable and is currently a fellow of ...
    (Date:4/5/2019)... AUBURN, Mass. (PRWEB) , ... April 04, 2019 ... ... family is available with integrated linear encoders providing 0.05 microns and 0.005 microns ... prices. Many motor and drive variations are available, from fast DC-servo motors with ...
    (Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
    Breaking Biology News(10 mins):
    (Date:4/9/2019)... ... April 09, 2019 , ... ... the capacity of life sciences organizations to accelerate innovation and maximize productivity, announces ... in the past 12 months. , USDM’s Cloud Assurance is a ...
    (Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
    (Date:3/29/2019)... ... March 28, 2019 , ... ... testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s ... million, which is on top of the $1.7 million already awarded by CARB-X. ...
    (Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... sample collection, and analysis to a team of researchers at Nnamdi Azikiwe University ... by Dr. Nneka R. Agbokoba, PhD, of the Department of Medical Laboratory Sciences ...
    Breaking Biology Technology:
    Cached News: